Analysis of DOK-6 function in downstream signaling of RET in human neuroblastoma cells

Area of Science:

• Molecular Biology
• Cell Signaling
• Neuroscience

Background:

• The RET tyrosine kinase gene is crucial for neural development and implicated in diseases like Multiple Endocrine Neoplasia type 2 (MEN 2).
• Glial cell line-derived neurotrophic factor (GDNF) activates RET signaling, which requires adaptor proteins like the DOK (downstream of kinase) family.
• While DOK-1, -4, -5, and -6 are known to participate in GDNF-RET signaling, the specific function of DOK-6 in human cells is not well understood.

Purpose of the Study:

• To investigate the role of DOK-6 in the GDNF-RET signaling pathway within human cells, specifically neuroblastoma cells.
• To determine if DOK-6 phosphorylation and localization are affected by RET activation in human cells.
• To compare the functional impact and binding affinity of DOK-6 to RET with other DOK family members and SHC.

Main Methods:

• Investigated DOK-6 localization and phosphorylation in human neuroblastoma cells upon RET activation (MEN2A mutation or GDNF stimulation).
• Assessed the effect of DOK-6 on downstream signaling pathways and neurite outgrowth.
• Quantified the binding affinity of the DOK-6 phosphotyrosine-binding (PTB) domain to RET and compared it with DOK-1, DOK-4, and SHC.

Main Results:

• DOK-6 localized to the plasma membrane via its pleckstrin homology (PH) domain and was phosphorylated following RET activation.
• DOK-6 did not significantly influence downstream signaling or neurite outgrowth in human neuroblastoma cells.
• The binding affinity of the DOK-6 PTB domain to RET was considerably lower compared to DOK-1, DOK-4, and SHC PTB domains.

Conclusions:

• DOK-6 is involved in RET signaling in human cells but exerts a less significant influence compared to DOK-1, DOK-4, and SHC.
• The reduced binding affinity of DOK-6 to RET may explain its limited functional impact on downstream signaling and cellular processes like neurite outgrowth.